Owlstone Medical advances breath-based diagnostics with its Breath Biopsy® platform, enabling non-invasive detection of cancer and respiratory, liver, and infectious diseases. The platform includes the ReCIVA® Breath Sampler, a commercial-scale Breath Laboratory (Cambridge, UK), and the Breath Biopsy VOC Atlas®. Pipeline tests target early lung cancer and liver disease via EVOC® probes. Under OMED Health, UK tests for SIBO and carb malabsorption are live, with a handheld device + app coming.